202 related articles for article (PubMed ID: 19896677)
21. The side of pneumonectomy influences long-term survival in stage I and II non-small cell lung cancer.
Simón C; Moreno N; Peñalver R; González G; Alvarez-Fernández E; González-Aragoneses F;
Ann Thorac Surg; 2007 Sep; 84(3):952-8. PubMed ID: 17720406
[TBL] [Abstract][Full Text] [Related]
22. Clinical impact of segmentectomy compared with lobectomy under complete video-assisted thoracic surgery in the treatment of stage I non-small cell lung cancer.
Yamashita S; Chujo M; Kawano Y; Miyawaki M; Tokuishi K; Anami K; Yamamoto S; Kawahara K
J Surg Res; 2011 Mar; 166(1):46-51. PubMed ID: 19560164
[TBL] [Abstract][Full Text] [Related]
23. Does lobectomy achieve better survival and recurrence rates than limited pulmonary resection for T1N0M0 non-small cell lung cancer patients?
Chamogeorgakis T; Ieromonachos C; Georgiannakis E; Mallios D
Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):364-72. PubMed ID: 18641014
[TBL] [Abstract][Full Text] [Related]
24. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer.
Fernando HC; Santos RS; Benfield JR; Grannis FW; Keenan RJ; Luketich JD; Close JM; Landreneau RJ
J Thorac Cardiovasc Surg; 2005 Feb; 129(2):261-7. PubMed ID: 15678034
[TBL] [Abstract][Full Text] [Related]
25. Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes.
Bauman JE; Mulligan MS; Martins RG; Kurland BF; Eaton KD; Wood DE
Ann Thorac Surg; 2008 Nov; 86(5):1632-8; discussion 1638-9. PubMed ID: 19049763
[TBL] [Abstract][Full Text] [Related]
26. A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung carcinoma.
Ratto GB; Zino P; Mirabelli S; Minuti P; Aquilina R; Fantino G; Spessa E; Ponte M; Bruzzi P; Melioli G
Cancer; 1996 Jul; 78(2):244-51. PubMed ID: 8673999
[TBL] [Abstract][Full Text] [Related]
27. Arterial invasion predicts early mortality in stage I non-small cell lung cancer.
Pechet TT; Carr SR; Collins JE; Cohn HE; Farber JL
Ann Thorac Surg; 2004 Nov; 78(5):1748-53. PubMed ID: 15511466
[TBL] [Abstract][Full Text] [Related]
28. Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy.
Kim YT; Kang CH; Sung SW; Kim JH
Ann Thorac Surg; 2005 Apr; 79(4):1153-61; discussion 1153-61. PubMed ID: 15797043
[TBL] [Abstract][Full Text] [Related]
29. Stage IB nonsmall cell lung cancers: are they all the same?
Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
[TBL] [Abstract][Full Text] [Related]
30. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
31. Clinical implication of pulmonary excision for undiagnosed peripheral lung cancer.
Funakoshi Y; Sawabata N; Takeuchi Y; Kusumoto H; Kimura T; Maeda H
Interact Cardiovasc Thorac Surg; 2011 Nov; 13(5):485-9. PubMed ID: 21835845
[TBL] [Abstract][Full Text] [Related]
32. Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer.
Birdas TJ; Koehler RP; Colonias A; Trombetta M; Maley RH; Landreneau RJ; Keenan RJ
Ann Thorac Surg; 2006 Feb; 81(2):434-8; discussion 438-9. PubMed ID: 16427827
[TBL] [Abstract][Full Text] [Related]
33. Sublobar resection provides an equivalent survival after lobectomy in elderly patients with early lung cancer.
Okami J; Ito Y; Higashiyama M; Nakayama T; Tokunaga T; Maeda J; Kodama K
Ann Thorac Surg; 2010 Nov; 90(5):1651-6. PubMed ID: 20971281
[TBL] [Abstract][Full Text] [Related]
34. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence.
Hung JJ; Hsu WH; Hsieh CC; Huang BS; Huang MH; Liu JS; Wu YC
Thorax; 2009 Mar; 64(3):192-6. PubMed ID: 19252018
[TBL] [Abstract][Full Text] [Related]
35. Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients.
Petersen RP; Campa MJ; Sperlazza J; Conlon D; Joshi MB; Harpole DH; Patz EF
Cancer; 2006 Dec; 107(12):2866-72. PubMed ID: 17099880
[TBL] [Abstract][Full Text] [Related]
36. Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer.
Varlotto JM; Recht A; Flickinger JC; Medford-Davis LN; Dyer AM; Decamp MM
Cancer; 2009 Mar; 115(5):1059-69. PubMed ID: 19152440
[TBL] [Abstract][Full Text] [Related]
37. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.
Sienel W; Dango S; Kirschbaum A; Cucuruz B; Hörth W; Stremmel C; Passlick B
Eur J Cardiothorac Surg; 2008 Apr; 33(4):728-34. PubMed ID: 18261918
[TBL] [Abstract][Full Text] [Related]
38. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
[TBL] [Abstract][Full Text] [Related]
39. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
[TBL] [Abstract][Full Text] [Related]
40. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
